Fibroblast shifts in the hypertensive heart: How single cell RNA-sequencing will accelerate advancements in anti-fibrotic therapies is a research paper published in Journal of Molecular and Cellular Cardiology (2020). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
NHLBI NIH HHS
Grant: R56 HL141165
National Institutes of Health
Grant: 1R56HL141165-01
Identifying a Pathogenic Fibroblast Subpopulation to Target for Protection Against Cardiac Fibrosis
American Heart Association
National Institutes of Health
FWCI
0.14
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals